本发明公开了一种可见光催化的 N ‑甲酰基酰胺化合物的制备方法,该方法中以LED灯作为光源提供能量,经济易得的二、三级酰胺作为反应底物,氯化铜为催化剂,氧气为氧化剂,市场可购买的盐酸为添加剂,硝基甲烷为溶剂。与现有技术相比较,本发明方法具有以下优点:1)采用绿色、温和、环境友好的可见光催化的反应模式;2)反应体系简单且底物范围广,芳香族和脂肪族酰胺均适用于该方法;3)氧气作为绿色的氧化剂;4)反应产率较高;5)操作比较简单;6)原料廉价易得。
ARYL DIHYDROPYRIDINONES AND PIPERIDINONE MGAT2 INHIBITORS
申请人:Bristol-Myers Squibb Company
公开号:US20150315144A1
公开(公告)日:2015-11-05
The present invention provides compounds of Formula (I):
or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.
Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US10695328B2
公开(公告)日:2020-06-30
The present invention provides compounds of Formula (I):
or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.
[EN] 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES, OBESITY AND DYSLIPIDEMIA<br/>[FR] INHIBITEURS DE LA 11-BETA-HYDROXYSTEROIDE DESHYDROGENASE 1 UTILISABLES POUR LE TRAITEMENT DU DIABETE, DE L'OBESITE ET DE LA DYSLIPIDEMIE
申请人:——
公开号:WO2003104207A3
公开(公告)日:2004-03-25
4-Methyl-5-phenyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type I
作者:Yuping Zhu、Steven H. Olson、Anne Hermanowski-Vosatka、Steven Mundt、Kashmira Shah、Marty Springer、Rolf Thieringer、Samuel Wright、Jianying Xiao、Hratch Zokian、James M. Balkovec
DOI:10.1016/j.bmcl.2008.04.013
日期:2008.6
4-Methyl-5-phenyl-(1,2,4)-triazoles were identified as selective inhibitors of 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1). They were active in vitro and in an in vivo mouse pharmacodynamic (PD) model. The synthesis and structure activity relationships are presented. (c) 2008 Elsevier Ltd. All rights reserved.
Tricyclic diazepines vasopressin and oxytocin antagonists